| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 667712 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 16,7 ml | 6 mg/ml inyectable 16,7 ml | 45 | 1 | 34 | 1 vial de 16,7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667713 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 6 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 669790 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 669791 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 672297 | 70513 | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION , 4 bolsas de 1.448 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 1.448 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70513/70513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70513/70513_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-07-31 | 1 | 1 | 1 | 2009-07-31 | 2010-07-22 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 672582 | 70513 | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION , 4 bolsas de 1.904 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 1.904 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70513/70513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70513/70513_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-07-31 | 1 | 1 | 1 | 2009-07-31 | 2010-09-27 | 1 | 2016-10-05 | View Edit Delete | ||||||||||||
| 672521 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 20 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 672522 | 70886 | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | IRINOTECAN KABI 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 25 ml | 20 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70886/70886_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70886/70886_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-05-04 | 1 | 1 | 1 | 2009-05-04 | 2010-08-30 | 1 | 2019-01-31 | View Edit Delete | ||||||||||||
| 676509 | 73054 | ROPIVACAINA KABI 2MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 2MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 2 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73054/73054_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73054/73054_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 676514 | 73056 | ROPIVACAINA KABI 7,5 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 7,5 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 7,5 mg/ml inyectable de 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73056/73056_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73056/73056_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 676516 | 73057 | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG | ROPIVACAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG , 5 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73057/73057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73057/73057_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-13 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 677339 | 73280 | HIDROCLORURO DE EFEDRINA KABI 30 mg/ml SOLUCION INYECTABLE | HIDROCLORURO DE EFEDRINA KABI 30 mg/ml SOLUCION INYECTABLE, 10 ampollas de 1 ml | 30 mg/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73280/73280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73280/73280_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-01-13 | 1 | 1 | 1 | 2011-01-13 | 2011-01-13 | 0 | 2020-04-02 | View Edit Delete | ||||||||||||
| 680397 | 61021 | VITALIPID INFANTIL | VITALIPID INFANTIL, 10 ampollas de 10 ml | 135,3 microgramos/ml + 1 microgramos/ml + 20 microgramos/ml + 640 microgramos/ml inyectable 10 ml | 1 | 10 | 1 | 10 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61021/61021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61021/61021_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 680405 | 61020 | VITALIPID ADULTOS | VITALIPID ADULTOS, 10 ampollas de 10 ml | 194,1 microgramos/ml + 0,5 microgramos/ml + 15 microgramos/ml + 910 microgramos/ml inyectable 10 ml | 1 | 10 | 1 | 10 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61020/61020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61020/61020_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 676512 | 73055 | ROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUSION EFG | ROPIVACAINA KABI 2 MG/ML SOLUCION PARA PERFUSION EFG , 5 bolsas de 100 ml | 2 mg/ml inyectable 10 ml | 3 | 5 | 65 | 5 bolsas de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73055/73055_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73055/73055_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2014-11-11 | 1 | 1 | 1 | 2014-11-11 | 2014-11-14 | 1 | 2015-05-26 | View Edit Delete | ||||||||||||
| 677138 | 61228 | SOLUVIT LIOFILIZADO PARA SOLUCION PARA PERFUSION | SOLUVIT LIOFILIZADO PARA SOLUCION PARA PERFUSION, 10 viales | N/A (más de 4 PA) | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61228/61228_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61228/61228_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 679314 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 40 ml | 5 mg/ml inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2014-04-17 | View Edit Delete | ||||||||||||
| 692725 | 43165 | INTRALIPID 200 mg/ml EMULSION PARA PERFUSION | INTRALIPID 200 mg/ml EMULSION PARA PERFUSION, 1 bolsa de 250 ml | 200 mg/ml inyectable 250 ml | 3 | 1 | 65 | 1 bolsa de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/43165/43165_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/43165/43165_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1972-01-01 | 1 | 1 | 1 | 1972-01-01 | 2012-08-09 | 1 | 2013-06-28 | View Edit Delete | ||||||||||||
| 692726 | 43165 | INTRALIPID 200 mg/ml EMULSION PARA PERFUSION | INTRALIPID 200 mg/ml EMULSION PARA PERFUSION, 1 bolsa de 500 ml | 200 mg/ml inyectable 500 ml | 3 | 1 | 65 | 1 bolsa de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/43165/43165_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/43165/43165_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1972-01-01 | 1 | 1 | 1 | 1972-01-01 | 2012-08-09 | 1 | 2013-06-28 | View Edit Delete | ||||||||||||
| 697242 | 77261 | ACIDO ZOLEDRONICO KABI 4MG/5ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ACIDO ZOLEDRONICO KABI 4MG/5ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5ml | 0,8 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77261/77261_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77261/77261_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2013-03-08 | 1 | 1 | 1 | 2013-03-08 | 2013-03-08 | 1 | 2014-04-17 | View Edit Delete |
Page 142 of 1036, showing 20 records out of 20709 total, starting on record 2821, ending on 2840